Eurofins Scientific SE (ERFSF) Financials
ERFSF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 12.7 billion | 8.5 billion |
| Dec. 31, 2025 | 12.9 billion | 8.7 billion |
| June 30, 2025 | 12.5 billion | 7.0 billion |
| Dec. 31, 2024 | 11.3 billion | 5.7 billion |
ERFSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 437.6 million | ? |
| Dec. 31, 2025 | 294.4 million | ? |
| June 30, 2025 | 359.5 million | 65.8 million |
| Dec. 31, 2024 | 497.4 million | 84.0 million |
ERFSF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 344.2 million |
| Dec. 31, 2025 | 268.0 million |
| June 30, 2025 | 290.7 million |
| Dec. 31, 2024 | 347.7 million |
ERFSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 704.3 million | 5.4 billion | - |
| Dec. 31, 2025 | 928.3 million | 4.0 billion | 511.7 million |
| June 30, 2025 | 887.9 million | 3.7 billion | 657.1 million |
| Dec. 31, 2024 | 639.3 million | 2.8 billion | 632.6 million |
ERFSF Shares Outstanding
ERFSF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 217.7 million | - | - | - |
| Dec. 31, 2025 | 632.2 million | - | - | - |
| June 30, 2025 | 260.8 million | - | 65.8 million | - |
| Dec. 31, 2024 | 323.8 million | - | -60.0 million | - |
ERFSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 4.2 billion | 3.6 billion |
| Dec. 31, 2025 | 4.3 billion | 3.9 billion |
| June 30, 2025 | 4.3 billion | 3.3 billion |
| Dec. 31, 2024 | 3.7 billion | -440.8 million |
ERFSF
Price: $82.93
52 week price:
Dividend Yield: 1.07%
5-year range yield:
Forward Dividend Yield: 1.02%
Dividend Per Share: 0.84 USD
Earnings Per Share: 3.28 USD
P/E Ratio: 23.63
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 13.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 6
DGR3: 15.39%